N1-Methyl-lysergic acid diethylamide

N1-Methyl-lysergic acid diethylamide
Clinical data
Other names	MLD-41, N1- Methyl- Lysergic Acid Diethylamide
Routes of; administration	Oral
Pharmacokinetic data
Metabolism	hepatic
Excretion	renal
Identifiers
	IUPAC name (8β)-N,N-Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide;
CAS Number	4238-85-1 ;
PubChem CID	165200;
ChemSpider	144824 ;
Chemical and physical data
Formula	C21H27N3O
Molar mass	337.47 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N(CC)CC)[C@@H]3/C=C2/c4cccc1c4c(cn1C)C[C@H]2N(C3)C;
	InChI InChI=1S/C21H27N3O/c1-5-24(6-2)21(25)15-10-17-16-8-7-9-18-20(16)14(12-22(18)3)11-19(17)23(4)13-15/h7-10,12,15,19H,5-6,11,13H2,1-4H3/t15-,19-/m1/s1 ; Key:VQZYKSWQIQANKB-DNVCBOLYSA-N ;
(verify)

N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD.

Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals.[1]

References

Müller-Schweinitzer and Tapparelli (1986). Methylergometrine, an active metabolite of methysergide. Cephalalgia. 6: 35-41.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.